Abstract
The influence of age, sex, pregnancy and protein-calorie malnutrition (PCM) on the plasma t1/2, plasma clearance (Clp) and apparent volume of distribution (Vd) of sodium salicylate (62 mumol kg-1) was determined in Sprague-Dawley rats. Female and male rats of five different age groups (ages in weeks: pups 1, weanling 3, young 8-9, adult including pregnant 14-15, old 56-60) including three age groups with PCM (8-9, 14-15 and 56-60 weeks old) were used. Plasma and urinary salicylates were assayed by h.p.l.c. Plasma t1/2 was longer and Clp smaller in pups than in weanling and young rats and comparable to values for old rats; Vd of salicylate in pups was larger than in any other group of rats. Plasma t1/2 was longer and Clp as well as Vd of salicylate were smaller in adult females than in males of comparable age. Relative to nonpregnant adult females, Vd of salicylate in pregnant rats was larger but plasma t1/2 and Clp were unchanged. In all groups of rats studied, PCM decreased the plasma t1/2 and increased the Clp of salicylate; Vd was unchanged. Changes in salicylate pharmacokinetics were not due to any differences in serum protein-salicylate binding or to serum testosterone levels. Ovariectomy decreased the plasma t1/2 of salicylate but castration of male rats had no significant effect. Administration of testosterone to ovariectomized female rats exerted no significant effect on salicylate pharmacokinetics. It is concluded that the physiological state and the nutritional status can modify salicylate pharmacokinetics; in so far as the rat model reflects the human situation, these variables should be taken into account for a rational salicylate therapy.
Full text
PDF







Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cuny G., Royer R. J., Mur J. M., Serot J. M., Faure G., Netter P., Maillard A., Penin F. Pharmacokinetics of salicylates in elderly. Gerontology. 1979;25(1):49–55. doi: 10.1159/000212320. [DOI] [PubMed] [Google Scholar]
- Davis L. E., Westfall B. A., Short C. R. Biotransformation and pharmacokinetics of salicylate in newborn animals. Am J Vet Res. 1973 Aug;34(8):1105–1108. [PubMed] [Google Scholar]
- Garrettson L. K., Procknal J. A., Levy G. Fetal acquisition and neonatal elimination of a large amount of salicylate. Study of a neonate whose mother regularly took therapeutic doses of aspirin during pregnancy. Clin Pharmacol Ther. 1975 Jan;17(1):98–103. doi: 10.1002/cpt197517198. [DOI] [PubMed] [Google Scholar]
- Giudicelli J. F., Tillement J. P. Influence of sex on drug kinetics in man. Clin Pharmacokinet. 1977 May-Jun;2(3):157–166. doi: 10.2165/00003088-197702030-00001. [DOI] [PubMed] [Google Scholar]
- Hutt A. J., Caldwell J., Smith R. L. The metabolism of [carboxyl-14C]aspirin in man. Xenobiotica. 1982 Oct;12(10):601–610. doi: 10.3109/00498258209042038. [DOI] [PubMed] [Google Scholar]
- Illing H. P., Wilson I. D. pH dependent formation of beta-glucuronidase resistant conjugates from the biosynthetic ester glucuronide of isoxepac. Biochem Pharmacol. 1981 Dec 15;30(24):3381–3384. doi: 10.1016/0006-2952(81)90620-1. [DOI] [PubMed] [Google Scholar]
- KATO R., VASSANELLI P., FRONTINO G., CHIESARA E. VARIATION IN THE ACTIVITY OF LIVER MICROSOMAL DRUG-METABOLIZING ENZYMES IN RATS IN RELATION TO THE AGE. Biochem Pharmacol. 1964 Jul;13:1037–1051. doi: 10.1016/0006-2952(64)90100-5. [DOI] [PubMed] [Google Scholar]
- Kato R., Onoda K. Studies on the regulation of the activity of drug oxidation in rat liver microsomes by androgen and estrogen. Biochem Pharmacol. 1970 May;19(5):1649–1660. doi: 10.1016/0006-2952(70)90154-1. [DOI] [PubMed] [Google Scholar]
- Krauer B., Krauer F. Drug kinetics in pregnancy. Clin Pharmacokinet. 1977 May-Jun;2(3):167–181. doi: 10.2165/00003088-197702030-00002. [DOI] [PubMed] [Google Scholar]
- Krishnaswamy K. Drug metabolism and pharmacokinetics in malutrition. Clin Pharmacokinet. 1978 May-Jun;3(3):216–240. doi: 10.2165/00003088-197803030-00003. [DOI] [PubMed] [Google Scholar]
- LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
- Levy G., Garrettson L. K. Kinetics of salicylate elimination by newborn infants of mothers who ingested aspirin before delivery. Pediatrics. 1974 Feb;53(2):201–210. [PubMed] [Google Scholar]
- Levy G. Pharmacokinetics of salicylate in man. Drug Metab Rev. 1979;9(1):3–19. doi: 10.3109/03602537909046431. [DOI] [PubMed] [Google Scholar]
- Menguy R., Desbaillets L., Masters Y. F., Okabe S. Evidence for a sex-linked difference in aspirin metabolism. Nature. 1972 Sep 8;239(5367):102–103. doi: 10.1038/239102a0. [DOI] [PubMed] [Google Scholar]
- Montgomery P. R., Sitar D. S. Increased serum salicylate metabolites with age in patients receiving chronic acetylsalicylic acid therapy. Gerontology. 1981;27(6):329–333. doi: 10.1159/000212493. [DOI] [PubMed] [Google Scholar]
- Nelson E., Hanano M., Levy G. Comparative pharmacokinetics of salicylate elimination in man and rats. J Pharmacol Exp Ther. 1966 Jul;153(1):159–166. [PubMed] [Google Scholar]
- O'Malley K., Crooks J., Duke E., Stevenson I. H. Effect of age and sex on human drug metabolism. Br Med J. 1971 Sep 11;3(5775):607–609. doi: 10.1136/bmj.3.5775.607. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Peng G. W., Gadalla M. A., Smith V., Peng A., Chiou W. L. Simple and rapid high-pressure liquid chromatographic simultaneous determination of aspirin, salicylic acid, and salicyluric acid in plasma. J Pharm Sci. 1978 May;67(5):710–712. doi: 10.1002/jps.2600670540. [DOI] [PubMed] [Google Scholar]
- Rainsford K. D., Ford N. L., Brooks P. M., Watson H. M. Plasma aspirin esterases in normal individuals, patients with alcoholic liver disease and rheumatoid arthritis: characterization and the importance of the enzymic components. Eur J Clin Invest. 1980 Oct;10(5):413–420. doi: 10.1111/j.1365-2362.1980.tb00054.x. [DOI] [PubMed] [Google Scholar]
- Robaire B., Ewing L. L., Irby D. C., Desjardins C. Interactions of testosterone and estradiol-17 beta on the reproductive tract of the male rat. Biol Reprod. 1979 Sep;21(2):455–463. doi: 10.1095/biolreprod21.2.455. [DOI] [PubMed] [Google Scholar]
- Scheer H., Robaire B. Steroid delta 4-5 alpha-reductase and 3 alpha-hydroxysteroid dehydrogenase in the rat epididymis during development. Endocrinology. 1980 Oct;107(4):948–953. doi: 10.1210/endo-107-4-948. [DOI] [PubMed] [Google Scholar]
- Schmucker D. L. Age-related changes in drug disposition. Pharmacol Rev. 1978 Dec;30(4):445–456. [PubMed] [Google Scholar]
- Sinclair K. A., Caldwell J. The formation of beta-glucuronidase resistant glucuronides by the intramolecular rearrangement of glucuronic acid conjugates at mild alkaline pH. Biochem Pharmacol. 1982 Mar 15;31(6):953–957. doi: 10.1016/0006-2952(82)90326-4. [DOI] [PubMed] [Google Scholar]
- Teunissen M. W., Srivastava A. K., Breimer D. D. Influence of sex and oral contraceptive steroids on antipyrine metabolite formation. Clin Pharmacol Ther. 1982 Aug;32(2):240–246. doi: 10.1038/clpt.1982.154. [DOI] [PubMed] [Google Scholar]
- Varma D. R. Influence of dietary protein on the anti-inflammatory and ulcerogenic effects and on the pharmacokinetics of phenylbutazone in rats. J Pharmacol Exp Ther. 1979 Nov;211(2):338–344. [PubMed] [Google Scholar]
- Varma D. R., Yue T. L. The influence of maternal protein deficiency on the placental transfer of salicylate in rats. Br J Pharmacol. 1983 Jan;78(1):233–238. doi: 10.1111/j.1476-5381.1983.tb09384.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yue T. L., Varma D. R. Pharmacokinetics, metabolism and disposition of salicylate in protein-deficient rats. Drug Metab Dispos. 1982 Mar-Apr;10(2):147–152. [PubMed] [Google Scholar]
